Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

Elias Jabbour, Nicholas J. Short, Nitin Jain, Xuelin Huang, Guillermo Montalban-Bravo, Pinaki Banerjee, Katayoun Rezvani, Xianli Jiang, Kun Hee Kim, Rashmi Kanagal-Shamanna, Joseph D. Khoury, Keyur Patel, Tapan M. Kadia, Naval Daver, Kelly Chien, Yesid Alvarado, Guillermo Garcia-Manero, Ghayas C. Issa, Fadi G. Haddad, Monica KwariJennifer Thankachan, Ricardo Delumpa, Walid Macaron, Rebecca Garris, Marina Konopleva, Farhad Ravandi, Hagop Kantarjian

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences